Hypothyroidism Treatment: Comparing Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine+Liothyronine

Looking for the best treatment for hypothyroidism? Learn about the comparative effectiveness of levothyroxine, desiccated thyroid extract, and levothyroxine+liothyronine in this informative article.

DR T S DIDWAL, MD

9/26/20237 min read

woman in teal scrub suit sitting beside man in white medical scrub suit
woman in teal scrub suit sitting beside man in white medical scrub suit

When it comes to managing hypothyroidism, one of the most critical decisions you and your healthcare provider will make is choosing the right thyroid medication. Hypothyroidism, a condition where the thyroid gland fails to produce enough thyroid hormone, can have a significant impact on your overall health and well-being. Two of the most commonly prescribed medications for treating hypothyroidism are desiccated thyroid extract and levothyroxine. In this comprehensive guide, we'll delve deep into the world of thyroid medications, comparing desiccated thyroid extract and levothyroxine to help you make an informed decision about which one is best suited for your specific needs.

Understanding Hypothyroidism

Before we dive into the specifics of these two medications, let's briefly review what hypothyroidism is and why it's essential to manage it effectively.

Hypothyroidism is a condition characterized by an underactive thyroid gland, which leads to a deficiency of thyroid hormones in the body. Thyroid hormones are crucial for regulating various bodily functions, including metabolism, energy production, and temperature control. When thyroid hormone levels are too low, it can result in a wide range of symptoms, such as fatigue, weight gain, hair loss, depression, and more.

Desiccated Thyroid Extract: The Natural Option

Desiccated thyroid extract, often derived from porcine (pig) thyroid glands, is a medication that contains both thyroxine (T4) and triiodothyronine (T3) hormones. These hormones are identical to the ones produced by the human thyroid gland, making desiccated thyroid extract a natural treatment option. Some of the key points to consider when it comes to desiccated thyroid extract include:

1. Natural Hormone Balance

One of the primary advantages of desiccated thyroid extract is its ability to provide a balanced ratio of both T4 and T3 hormones. T4 is typically converted into the active T3 hormone in the body, and having both in the medication can mimic the natural thyroid hormone balance more closely.

2. Potential for Improved Symptom Relief

Because desiccated thyroid extract contains both T4 and T3, some individuals find that it offers better relief from hypothyroid symptoms compared to levothyroxine alone. The presence of T3 in the medication can lead to more immediate symptom improvement.

3. Considerations for Allergies

It's essential to note that desiccated thyroid extract is derived from animal sources, primarily pigs. This may be a concern for individuals with allergies to pork products.

Levothyroxine: The Standard Treatment

Levothyroxine, on the other hand, is a synthetic thyroid hormone medication that contains only T4 hormone. It has been the standard treatment for hypothyroidism for many years, and here are some key considerations:

1. Stable and Consistent Dosage

One of the advantages of levothyroxine is its stability and consistency. The medication is precisely dosed, making it easier for healthcare providers to regulate thyroid hormone levels in the body.

2. Fewer Allergenic Concerns

Because levothyroxine is synthetic, it eliminates the allergenic concerns associated with desiccated thyroid extract, which is derived from animal sources.

3. Widespread Acceptance

Levothyroxine has a long history of successful use in treating hypothyroidism and is widely accepted as a standard treatment option by healthcare professionals.

Choosing the Right Medication

The choice between desiccated thyroid extract and levothyroxine ultimately depends on individual factors, including your specific symptoms, preferences, and any allergies you may have. Here are some essential considerations to help guide your decision:

1. Symptom Management

If you are experiencing persistent or severe hypothyroid symptoms and desire more immediate relief, desiccated thyroid extract may be worth discussing with your healthcare provider.

2. Allergies

Individuals with allergies to pork or concerns about animal-derived medications may prefer levothyroxine due to its synthetic nature.

3. Stability

If you prefer a stable and consistent medication with a long track record of effectiveness, levothyroxine is a reliable choice.

4. Consult Your Healthcare Provider

Ultimately, the decision between desiccated thyroid extract and levothyroxine should be made in consultation with your healthcare provider. They can assess your individual needs, conduct necessary tests, and tailor the treatment to your specific situation.

Unlocking the Potential of Combination Thyroid Hormone Therapy: A Breakthrough Study

The management of hypothyroidism, a common endocrine disorder characterized by an underactive thyroid gland, has long been centered around the administration of levothyroxine (LT4), a synthetic form of the thyroid hormone thyroxine (T4). This treatment approach has proven effective for many patients, helping them achieve normal serum thyrotropin (TSH) levels and alleviating symptoms associated with hypothyroidism. However, the one-size-fits-all approach of LT4 monotherapy may not provide optimal results for all patients, leaving some individuals with persistent symptoms and a reduced quality of life.

Recent research has shed light on the potential benefits of combination thyroid hormone therapy, which includes the use of both LT4 and liothyronine (T3), or desiccated thyroid extract (DTE) containing both T4 and T3. To our knowledge, this is the first randomized, double-blind, crossover study that delves deep into the comparison of LT4 vs. DTE vs. LT4/LT3 therapy in hypothyroid patients. The groundbreaking results of this study have the potential to reshape the way we approach hypothyroidism treatment.

The Key Findings

In a study that included a group of 75 hypothyroid patients, the results reaffirmed previous trials in which no significant differences were observed between LT4 monotherapy and combination therapy. Treatment preferences were largely consistent, and the etiology of hypothyroidism or the presence of the Thr92Ala-DIO2 gene polymorphism did not significantly impact the outcomes.

However, a subanalysis within the study revealed a remarkable revelation. Approximately one-third of the most symptomatic patients on LT4 monotherapy experienced significant improvement when switched to combination therapy containing T3, either LT4 + LT3 or DTE. These patients not only showed a preference for T3-containing therapy but also reported better scores on mood (measured by the Beck Depression Inventory) and cognitive assessments (evaluated using the Wechsler Memory Scale-IV). Additionally, two quality-of-life questionnaires, TSQ-36 and GHQ-12, further highlighted the substantial benefits of T3-containing therapy for these individuals.

The Complex Nature of Thyroid Hormone Signaling

To understand the implications of these findings, it's crucial to explore the complex nature of thyroid hormone signaling. Traditionally, serum TSH levels have been the primary indicator used to adjust LT4 doses to achieve normal thyroid hormone signaling in all tissues. However, the normalization of serum TSH often involves a trade-off, resulting in slightly elevated serum T4 levels and reduced serum T3 levels.

In this study, TSH levels were higher in the DTE arm but remained within the normal range. Achieving bioequivalence between DTE and LT4 doses proved challenging. Interestingly, the elevation in serum T3 and the reduction in serum T4 associated with treatment containing T3 or DTE correlated with a significant mitigation of residual hypothyroid symptoms. This observation suggests a potential causal relationship between these changes in hormone levels and symptom improvement.

However, the study also presented an intriguing conundrum: no direct correlation between serum T3 levels and treatment outcomes could be established, even in subanalyses. This leads us to consider that intracellular T3 levels, influenced by both serum T3 and locally generated T3, may play a crucial role in thyroid hormone signaling and patient responsiveness to therapy.

The Intricate Role of Thyroid Hormone in the Brain

The brain's response to thyroid hormone is intricate and multifaceted, with significant impacts on mood, behavior, and cognition. It's known that the human brain, particularly the temporal pole, is highly sensitive to even minimal changes in thyroid hormone signaling. Most T3 molecules in the brain are locally produced in glial cells through the deiodination of T4 via DIO2. T3 then acts in a paracrine fashion to activate neuronal gene expression.

Despite the administration of LT4, some patients remain symptomatic, indicating that LT4 monotherapy may not fully restore cerebral thyroid hormone levels in all individuals. Several factors, including defects in thyroid hormone transporters, the DIO2 pathway, or relatively low serum T3 levels in LT4-treated patients, have been proposed as potential explanations. However, none of these factors appear to segregate in the most symptomatic LT4-treated patients.

Unlocking the Potential of Combination Therapy

In light of these findings, it becomes evident that thyroid hormone signaling in the brain may not be fully restored in some patients on LT4 monotherapy, and one or more yet-to-be-identified mechanisms may be at play. What's truly remarkable is that the elevation in serum T3 resulting from treatment with LT4 + LT3 or DTE appears to mitigate this issue. Importantly, these therapeutic interventions did not result in any associated cardiovascular adverse reactions or changes in blood pressure, and heart rate was only minimally accelerated by DTE therapy.

The Subanalyses and Future Directions

The subanalyses conducted in this study focused on values obtained during LT4 monotherapy, comparing them to values obtained at the end of DTE or LT4 + LT3 study periods. While "regression to the mean" may be a consideration, several observations argue against it. Parameters identified as responsive to therapy containing T3, such as quality of life questionnaires and cognitive tests, consistently exhibited intrinsic consistency and are unlikely to be random findings.

Moreover, patients who performed poorly on LT4 monotherapy also demonstrated a strong preference for alternative therapies, indicating their awareness of treatment efficacy. However, it's worth noting that not all patients who fared poorly on LT4 improved consistently when switched to other treatments, suggesting that mean reversion alone cannot account for the observed effects. Future studies specifically designed to focus on symptomatic patients on LT4 monotherapy should further elucidate these findings.

Conclusion

In conclusion, this groundbreaking study has brought to light a critical aspect of hypothyroidism management. While LT4 monotherapy has proven effective for many patients, a subset of individuals remains symptomatic despite normal serum TSH levels. The subanalysis conducted in this study identified these patients as having the worst performance on quality-of-life questionnaires and cognitive tests. Significantly, these individuals demonstrated a strong preference for and benefit from switching to therapy containing T3, whether in the form of DTE or LT4 + LT3 combination therapy.

These findings challenge the conventional approach to hypothyroidism treatment and suggest that thyroid hormone signaling in some LT4-treated patients may not be fully restored. Instead, therapy containing T3 has the potential to provide substantial relief and improve the quality of life for this subset of patients. This research opens the door to further investigations into the intricate mechanisms underlying thyroid hormone signaling and responsiveness to therapy.

Reference Article:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530721/

Related Article:

The Link Between Stress and Coronary Heart Disease | Healthnewstrend

Disclaimer

The information on this website is for educational and informational purposes only, and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment, and before undertaking a new healthcare regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.